Guidelines for treating iron overload in myelodysplastic syndromes: a Taiwan consensus statement
- First Online:
- Cite this article as:
- Ko, BS., Chang, CS., Chang, MC. et al. Int J Hematol (2014) 100: 7. doi:10.1007/s12185-014-1607-x
- 340 Downloads
Iron overload is common in myelodysplastic syndrome (MDS) patients, and an accumulation of evidence shows that iron chelation may have benefits in these patients. However, discussion and consensus about iron chelation therapy (ICT) for MDS patients is lacking in Taiwan and other Southeast Asian countries. An Expert Panel in Taiwan was organized in 2011 to develop iron overload guidelines and provide a uniform reference for physicians treating MDS patients with iron overload, with specific regard to when to initiate ICT, in which patients, and the clinical and scientific rationale behind its use.